We showed that ELAVL1 affects HBx, which might be one of the reasons for the results that RFS in ELAVL1low HBV-related HCC patients tended to be better than that in ELAVL1high HBV-related HCC patients. This evidence concerns the gene ELAVL1 and hepatocellular carcinoma.